Adeolu Oluremi
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Adeolu Oluremi's research focuses on the development of ionic nanomedicines for cancer therapy. Their work involves creating near-infrared-responsive nanomedicines that utilize macrocyclic histone deacetylase inhibitors to enhance treatment efficacy. This approach aims to improve drug delivery and therapeutic outcomes in cancer patients.
Oluremi collaborates with researchers at the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, and Shahedur Rahman, as well as Mahfuzul Hassan from Philander Smith College. Their shared publications indicate a collaborative effort in advancing cancer treatment methodologies.
Metrics
- Publications: 1
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
Collaboration Network
Top Collaborators
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
Similar Researchers
Based on overlapping research topics